This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Protalix BioTherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: PLX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PLX?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	2,385,331	4.16%
Individual Insiders	4,409,378	7.68%
Institutions	5,254,617	9.16%
General Public	45,331,654	79%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26%.

Top Shareholders

Top 25 shareholders own 20.68% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.21%	Highbridge Capital Management, LLC	2,413,487	₪17.1m	0%	0.14%
4.16%	Al-Rov Properties & Building (1983) Ltd	2,385,331	₪16.9m	0%	no data
4.12%	- Chinar	2,362,783	₪16.8m	0%	no data
2.4%	Medical Strategy GmbH, Asset Management Arm	1,377,397	₪9.8m	0%	0.2%
2.01%	Dror Bashan	1,153,458	₪8.2m	0%	no data
0.64%	Eyal Rubin	368,097	₪2.6m	0%	no data
0.43%	Meitav Investment House Ltd	244,482	₪1.7m	0.06%	no data
0.39%	Renaissance Technologies LLC	224,603	₪1.6m	91.6%	no data
0.38%	Zeev Bronfeld	216,247	₪1.5m	0%	no data
0.3%	Aharon Schwartz	174,000	₪1.2m	172%	no data
0.23%	Bridgeway Capital Management, LLC	133,790	₪950.2k	0%	0.01%
0.22%	Citadel Advisors LLC	124,307	₪882.8k	112%	no data
0.18%	BlackRock, Inc.	101,893	₪723.7k	3.17%	no data
0.16%	Jane Street Group, LLC, Asset Management Arm	92,219	₪654.9k	17.5%	no data
0.12%	Technorov Holdings Ltd.	68,604	₪487.2k	0%	100.0%
0.11%	I.B.I Mutual Funds Management (1978) Ltd.	61,279	₪435.2k	-4.93%	0.02%
0.11%	Migdal Mutual Funds Ltd.	61,241	₪435.0k	-1.34%	no data
0.1%	Alfred Akirov	59,680	₪423.9k	0%	no data
0.087%	Wilcoxson Wealth Management	50,100	₪355.8k	0%	no data
0.064%	Chinar Shah	36,450	₪258.9k	0%	no data
0.063%	Canadian Imperial Bank of Commerce, Asset Management Arm	36,000	₪255.7k	0%	no data
0.059%	Psagot Index Funds Ltd	34,044	₪241.8k	-4.59%	no data
0.055%	Dolphin 1 Investments Ltd.	31,315	₪222.4k	-20.5%	0.51%
0.047%	IHT Wealth Management LLC	26,800	₪190.4k	21.8%	no data
0.045%	Capital Performance Advisors Llp	25,974	₪184.5k	0%	0.03%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/03/23 13:23
End of Day Share Price	2023/03/20 00:00
Earnings	2022/12/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Protalix BioTherapeutics, Inc. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Ritu Baral	Canaccord Genuity
Difei Yang	Capstone Investments
Peter Welford	Jefferies LLC